Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer’s disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the...
New SDRC Executive Committee Member: Stina Saunders

New SDRC Executive Committee Member: Stina Saunders

Our final announcement of new SDRC Executive Committee members is Stina Saunders. We are delighted to have Stina joining us and look forward to working with her and all the new members. Find out more about Stina in the blog below.   I am in the final year of my PhD at...
New SDRC Executive Committee Member: Dr Tom Russ

New SDRC Executive Committee Member: Dr Tom Russ

Following our recent SDRC Executive Committee election, we have seven new researchers join us.  The full list of members is available here. We are delighted to announce Dr Tom Russ as one of the newest members. Find out more about Tom below.  I trained in medicine and...
New SDRC Executive Committee Member- Dr Mario Parra Rodriguez

New SDRC Executive Committee Member- Dr Mario Parra Rodriguez

Following the SDRC Executive Committee 2021 elections, we are delighted to introduce our new members. Today’s blog post features Dr Mario Parra Rodriguez. Read more about Mario below I graduated as a Medical Doctor in 1993 and as a Clinical Neurophysiologist in...
SDRC Executive Committee Support: Dr Terry Quinn

SDRC Executive Committee Support: Dr Terry Quinn

You may have read in our previous blog that we now have two new academics which will provide support to the SDRC Executive Committee with our growing activity. This support will run until our next Executive Committee election at the end of 2020.  The second of these...